Avantor® to Boost Global Production of Single-Use Technologies and Address Growing Biopharma Demand
RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
Dr. Brophy: Biopharma looks to Avantor to know and support requirements as they rapidly expand manufacturing capacity
In the U.S. and Europe, the Company will increase its single-use manufacturing footprint by 30% and double its cleanroom space. The investment will support growing customer demand for monoclonal antibodies (mAbs), novel cell and gene therapies for oncology and other diseases, as well as vaccines, including those for COVID-19.
Avantor recently expanded its Morrisville, North Carolina, single-use facility and expects completion of a cleanroom expansion at its Devens, Massachusetts, operation by mid-year. The Company also expects to open its second European single-use facility in Hillegom, the Netherlands, by then as well.
Dr. Ger Brophy, Executive Vice President of Biopharma Production at Avantor, said, "The industry's response to the COVID-19 pandemic has relied heavily on the integration of single-use products into biopharma production processes. Efficacy and safety are of the utmost importance to our customers, and they look to us to understand and support their requirements as they rapidly expand their own manufacturing capacity.
"These additions to our global single-use manufacturing ecosystem are critical steps in enabling our customers to get therapies to patients quickly," Brophy added.
The investment further strengthens the Company's single-use network, providing product consistency and capabilities close to bioproduction customers to help ensure efficient and uninterrupted supply.
Watch this video for more information about how Avantor's single-use solutions support biopharma manufacturing.
Global Media Contact
SOURCE Avantor and Financial News
Company Codes: NYSE:AVTR